Bo-bo Wang

Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer.

Yi Chen, Jian Ding, Ling-hua Meng, 2018, Cancer letters.

Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3Kα inhibition in breast cancer

Qiao-jun He, Linghua Meng, Xi Zhang, 2019, Signal Transduction and Targeted Therapy.

Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yi Chen, Jian Ding, Linghua Meng, 2019, Cancer biology & medicine.

Simultaneous inhibition of PI 3 Kα and CDK 4 / 6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Yi Chen, Jian Ding, Linghua Meng, 2019 .

Knockdown of NF-κB activating protein promotes pancreatic cancer growth and metastasis through mTOR signaling pathway

Xiangrong Xu, Yunqing Zhang, Yujie Wang, 2023, Molecular Biology Reports.